Comprehensive observational assessment: Ia. A systematic, quantitative procedure for assessing the behavioral and physiologic state of the mouse

Behavioral and functional analysis of mouse phenotype: SHIRPA, a proposed protocol for comprehensive phenotype assessment

Rogers, D. C., Fisher, E. M. C., Brown, S. D. M., Peters, J., Hunter, A. J., & Martin, J. E. (1997) · Mammalian Genome · doi:10.1007/s003359900551 · Cited by 795

Tests to assess motor phenotype in mice: a user's guide

Brooks, S. P., & Dunnett, S. B. (2009) · Nature Reviews Neuroscience · doi:10.1038/nrn2652 · Cited by 621

Animal models of human disease: challenges in enabling translation

McGonigle, P., & Ruggeri, B. (2014) · Biochemical Pharmacology · doi:10.1016/j.bcp.2013.08.006 · Cited by 610

Chronic Pharmacological mGlu5 Inhibition Corrects Fragile X in Adult Mice

Michalon, A., Sidorov, M., Ballard, T. M., Ozmen, L., Spooren, W., Wettstein, J. G., Jaeschke, G., Bear, M. F., & Lindemann, L. (2012) · Neuron · doi:10.1016/j.neuron.2012.03.009 · Cited by 489

Behavioral phenotyping strategies for mutant mice

Crawley, J. N. (2008) · Neuron · doi:10.1016/j.neuron.2008.03.001 · Cited by 439

Characterization of the 3xTg-AD mouse model of Alzheimer’s disease: Part 2. Behavioral and cognitive changes

Sterniczuk, R., Antle, M. C., LaFerla, F. M., & Dyck, R. H. (2010) · Brain Research · doi:10.1016/j.brainres.2010.06.011 · Cited by 228

Functional Aging in Male C57BL/6J Mice Across the Life-Span: A Systematic Behavioral Analysis of Motor, Emotional, and Memory Function to Define an Aging Phenotype

Yanai, S., & Endo, S. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.697621 · Cited by 171

Multi-metric behavioral comparison of APPsw and P301L models for Alzheimer's disease: linkage of poorer cognitive performance to tau pathology in forebrain

Arendash, G. W., Lewis, J., Leighty, R. E., McGowan, E., Cracchiolo, J. R., Hutton, M., & Garcia, M. F. (2004) · Brain Research · doi:10.1016/j.brainres.2004.02.081 · Cited by 127

Optimization of brain targeted chitosan nanoparticles of Rivastigmine for improved efficacy and safety

Nagpal, K., Singh, S. K., & Mishra, D. N. (2013) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2013.04.024 · Cited by 116

PIAS1 regulates mutant Huntingtin accumulation and Huntington’s disease-associated phenotypes in vivo

Ochaba, J., Monteys, A. M., O’Rourke, J. G., Reidling, J. C., Steffan, J. S., Davidson, B. L., & Thompson, L. M. (2016) · Neuron · doi:10.1016/j.neuron.2016.03.016 · Cited by 94

Assessment of Developmental Milestones in Rodents

Heyser, C. J. (2003) · Current Protocols in Neuroscience · doi:10.1002/0471142301.ns0818s25 · Cited by 93

Novel halogenated derivates of JWH-018: behavioral and binding studies in mice

Vigolo, A., Ossato, A., Trapella, C., Vincenzi, F., Rimondo, C., Seri, C., Varani, K., Serpelloni, G., & Marti, M. (2015) · Neuropharmacology · doi:10.1016/j.neuropharm.2015.02.008 · Cited by 91

Neuronal glucose transporter isoform 3 deficient mice demonstrate features of autism spectrum disorders

Zhao, Y., Fung, C., Shin, D., Shin, B.-C., Thamotharan, S., Sankar, R., Ehninger, D., Silva, A., & Devaskar, S. U. (2010) · Molecular Psychiatry · doi:10.1038/mp.2009.51 · Cited by 88

Assessing the predictive value of the rodent neurofunctional assessment for commonly reported adverse events in phase I clinical trials

Mead, A. N., Amouzadeh, H. R., Chapman, K., Ewart, L., Giarola, A., Jackson, S. J., Jarvis, P., Jordaan, P., Redfern, W., Traebert, M., et al. (2016) · Regulatory Toxicology and Pharmacology · doi:10.1016/j.yrtph.2016.05.002 · Cited by 67

A Toxicological Evaluation of Mango Leaf Extract (Mangifera indica) Containing 60% Mangiferin

Reddeman, R. A., Glávits, R., Endres, J. R., Clewell, A. E., Hirka, G., Vértesi, A., Béres, E., & Szakonyiné, I. P. (2019) · Journal of Toxicology · doi:10.1155/2019/4763015 · Cited by 54

Reproducibility and relevance of future behavioral sciences should benefit from a cross fertilization of past recommendations and today's technology: “Back to the future”

Spruijt, B. M., Peters, S. M., de Heer, R. C., Pothuizen, H. H. J., & van der Harst, J. E. (2014) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2014.03.001 · Cited by 53

Aligning physiology with psychology: Translational neuroscience in neuropsychiatric drug discovery

McArthur, R. A. (2017) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2017.02.004 · Cited by 42

Age-related influence of the HDL receptor SR-BI on synaptic plasticity and cognition

Chang, E. H., Rigotti, A., & Huerta, P. T. (2009) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2007.07.006 · Cited by 35

Preclinical Development of Nononcogenic Drugs (Small and Large Molecules)

Colerangle, J. B. (2017) · A Comprehensive Guide to Toxicology in Nonclinical Drug Development · doi:10.1016/b978-0-12-803620-4.00025-6 · Cited by 37

Reduced benzodiazepine tolerance, but increased flumazenil-precipitated withdrawal in AMPA-receptor GluR-A subunit-deficient mice

Aitta-aho, T., Vekovischeva, O. Y., Neuvonen, P. J., & Korpi, E. R. (2009) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2008.12.015 · Cited by 18

A Toxicological Assessment of Creatyl- l -Leucine

Reddeman, R. A., Glávits, R., Endres, J. R., Murbach, T. S., Hirka, G., Vértesi, A., Béres, E., & Szakonyiné, I. P. (2018) · International Journal of Toxicology · doi:10.1177/1091581817751142 · Cited by 6

Evaluation of rewarding effects of nitazene analogs: results from conditioned place preference tests and in vivo microdialysis experiments in mice

Hataoka, K., Hojo, M., Nomura, S., Nakagawa, Y., Kawai, A., Nakamura, M., Ikushima, K., Alexander, D. B., Suzuki, J., Suzuki, T., et al. (2025) · The Journal of Toxicological Sciences · doi:10.2131/jts.50.33 · Cited by 5